Understanding why Black and Hispanic patients with Hodgkin lymphoma have lower survival rates
Determining Barriers Leading to Inferior Survival for Black and Hispanic Patients with Hodgkin Lymphoma: A Patient-Centered Study
This study is looking into why Black and Hispanic patients with Hodgkin lymphoma have lower survival rates, and it aims to find out what challenges they face so that we can create better support and treatment options for them.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11030387 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the lower survival rates of Black and Hispanic patients diagnosed with Hodgkin lymphoma. By analyzing comprehensive patient data, including social factors and treatment outcomes, the study aims to identify specific barriers that contribute to these disparities. The research will utilize advanced databases to link patient records and treatment histories, focusing on how these factors vary across different age groups. Ultimately, the goal is to develop targeted interventions to improve survival outcomes for these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black and Hispanic individuals diagnosed with Hodgkin lymphoma across all age groups.
Not a fit: Patients who are not Black or Hispanic or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and support systems for Black and Hispanic patients with Hodgkin lymphoma.
How similar studies have performed: Previous research has shown that addressing social determinants of health can significantly improve outcomes for marginalized patient populations, suggesting potential success for this approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Mailhot, Raymond B — University of Florida
- Study coordinator: Mailhot, Raymond B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.